Barclays Cuts Clorox (NYSE:CLX) Price Target to $132.00

Clorox (NYSE:CLX) had its price objective decreased by Barclays from $136.00 to $132.00 in a research note published on Thursday morning, Benzinga reports. Barclays currently has an underweight rating on the stock.

Several other equities analysts also recently weighed in on CLX. Citigroup reduced their price target on Clorox from $155.00 to $150.00 and set a neutral rating for the company in a report on Wednesday, May 1st. DA Davidson reaffirmed a neutral rating and issued a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. JPMorgan Chase & Co. dropped their target price on shares of Clorox from $159.00 to $158.00 and set a neutral rating on the stock in a research note on Wednesday, May 1st. UBS Group reduced their price target on shares of Clorox from $164.00 to $159.00 and set a neutral rating for the company in a research report on Wednesday, May 1st. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on Clorox from $155.00 to $151.00 and set a hold rating on the stock in a research report on Wednesday, April 17th. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to MarketBeat, the company has an average rating of Hold and an average price target of $146.43.

Clorox Stock Down 1.0 %

Shares of Clorox stock opened at $138.23 on Thursday. Clorox has a 1 year low of $114.68 and a 1 year high of $176.24. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.57. The company has a 50-day moving average of $148.45 and a 200 day moving average of $143.43. The firm has a market cap of $17.17 billion, a price-to-earnings ratio of 71.62, a PEG ratio of 2.16 and a beta of 0.44.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business’s revenue was down 5.3% on a year-over-year basis. During the same period last year, the business earned $1.51 earnings per share. As a group, sell-side analysts anticipate that Clorox will post 5.83 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.47%. Clorox’s dividend payout ratio is currently 248.71%.

Hedge Funds Weigh In On Clorox

Several institutional investors have recently made changes to their positions in the business. CIBC Private Wealth Group LLC increased its holdings in Clorox by 0.5% during the fourth quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after buying an additional 66 shares during the last quarter. Lindbrook Capital LLC increased its stake in shares of Clorox by 6.2% in the 1st quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after purchasing an additional 69 shares in the last quarter. First National Bank of Mount Dora Trust Investment Services raised its holdings in Clorox by 3.2% in the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock worth $322,000 after purchasing an additional 71 shares during the period. Modera Wealth Management LLC lifted its position in Clorox by 1.4% during the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock valued at $672,000 after purchasing an additional 71 shares in the last quarter. Finally, Czech National Bank grew its holdings in Clorox by 0.3% during the fourth quarter. Czech National Bank now owns 21,718 shares of the company’s stock valued at $3,097,000 after purchasing an additional 71 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.